Logo for Pivotal Therapeutics Inc.

Pivotal Therapeutics Inc.

Issued & Outstanding96,566,669
Reserved for Issuance10,680,384
CSE Index


Pivotal Therapeutics Inc.

Listing date
May 19, 2011

Pivotal Therapeutics Inc. is a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health. The company currently has two commercial products: VASCAZEN® is available in the US by prescription only and OMAZEN™ is available for sale as a natural health product in Canada.The company's lead product VASCAZEN® is a prescription only Medical Food for the treatment of an Omega-3 Deficiency (OM3D) in patients with cardiovascular disease. The company's second product OMAZEN® is an ultra pure Omega-3 for the maintenance of good health.